Abstract
Background
Scabies, caused by the mite, Sarcoptes scabiei, infects millions of humans, and many wild and domestic mammals. Scabies mites burrow in the lower stratum corneum of the epidermis of the skin and are the source of substances that are antigenic or modulate aspects of the protective response of the host. Ordinary scabies is a difficult disease to diagnose.
Objective
The goal of this project was to identify S. scabiei proteins that may be candidate antigens for use in a diagnostic test or may be used by the mite to modulate the host’s protective response.
Methods
An aqueous extract of S. scabiei was separated by 2-dimensional electrophoresis and proteins were identified by mass spectrometry. A parallel immunoblot was probed with serum from patients with ordinary scabies to identify IgM and/or IgG-binding antigens. The genes coding for 23 selected proteins were cloned into E. coli and the expressed recombinant proteins were screened with serum from patients with confirmed ordinary scabies.
Results
We identified 50 different proteins produced by S. scabiei, 34 of which were not previously identified, and determined that 66% were recognized by patient IgM and/or IgG. Fourteen proteins were screened for use in a diagnostic test but none possessed enough sensitivity and specificity to be useful. Six of the 9 proteins selected for the possibility that they may be immunomodulatory were not recognized by antibodies in patient serum.
Conclusions
Thirty-three proteins that bound IgM and/or IgG from the serum of patients with ordinary scabies were identified. None of the 14 tested were useful for inclusion in a diagnostic test. The identities of 16 proteins that are not recognized as antigens by infected patients were also determined. These could be among the molecules that are responsible for this mite’s ability to modulate its host’s innate and adaptive immune responses.
Author summary
Scabies, caused by the mite, Sarcoptes scabiei, infects millions of humans, and many wild and domestic mammals. Scabies mites burrow in the lower stratum corneum of the epidermis of the skin and are the source of substances that are antigenic or modulate aspects of the protective response of the host. Ordinary scabies is a difficult disease to diagnose. We identified 50 different proteins produced by S. scabiei, 33 of which bound IgM and/or IgG from the serum of patients with ordinary scabies. A set of 23 recombinant proteins were produced and screened for use in a diagnostic test but none possessed enough sensitivity and specificity to warrant further consideration although some could be among the molecules that are responsible for this mite’s ability to modulate its host’s innate and adaptive immune responses.
Introduction
Scabies is a worldwide disease that affects millions of humans, other species of primates, and many wild and domestic mammals. It is caused by the itch mite, Sarcoptes scabiei, that burrows in the lower stratum corneum of the epidermis of the skin. Scabies mites are the source of substances that modulate certain aspects of the inflammatory innate and adaptive immune response of the host allowing it to evade detection by the host until it is able to establish a thriving population [1–12]. Ordinary scabies is a difficult disease to diagnose and there are no diagnostic blood tests with adequate sensitivity and specificity available to identify patients early in the course of an infection [13].
The goal of this project was to identify S. scabiei proteins that (1) may be candidate antigens for use in a diagnostic test or (2) may be among those used by the mite to modulate the host’s protective responses.
Materials and methods
Ethics statement
Serum from patients with confirmed ordinary scabies was collected under Human Subjects Protocol (HSP) #0205 as approved by the Wright State University Institutional Review Board (IRB). All patients were adults and all provided written informed consent. Negative control sera were previously provided to us without personal identifiers under protocol SC #2714 approved as EXEMPT under CFR 46.101(b)(4) by the Wright State University IRB.
S. scabiei mite extract
An aqueous extract of Sarcoptes scabiei var. canis was prepared by homogenizing mites in endotoxin-free water as previously described [14]. Following two 24-hr extractions, the supernatants were collected by centrifugation, sterile-filtered (0.22 μm) into sterile vials and stored at 4°C. The protein content of this and all other samples was determined using the method of Bradford with bovine serum albumin (BSA) as standard [15].
Protein separation
Unless otherwise noted, the materials used for protein separation and analysis were obtained from Bio-Rad Laboratories, Inc., Hercules, CA.
Proteins in the S. scabiei extract (40 mL containing 175 mg protein) were concentrated using preparative isoelectric focusing (IEF) as previously described [16] using a Bio-Rad Rotofor apparatus with ampholytes of pH 3–10 (BioLyte 3/10, 2% wt/vol final) and 5% glycerol. Focusing at 5°C for 5 hr at 12 W yielded 20 fractions with pH 1.6–13. Fractions 4–15 (pH 4–8 containing ~ 120 mg protein) were recombined and subjected to a second IEF separation. Fraction 14 had the highest protein concentration (2.2 mg/mL) and a pH of 5.0 and was selected for further study.
Two-dimensional (2D) gel electrophoresis was performed as previously described [14]. An aliquot of Fraction 14 was prepared using the ReadyPrep 2-D Cleanup Kit and the resulting protein sample was extracted into ReadyPrep Rehydration/Sample Buffer. Two identical samples, each containing ~200 μg of protein, were loaded onto 11 cm ReadyStrip pH 5–8 IPG strips using overnight passive rehydration. Second dimension separation was carried out using Criterion TGX Any kD precast gels as before. At the conclusion of the electrophoretic separation, one gel was stained with GelCode Blue Stain Reagent (Thermo Scientific, Rockford, IL). The other gel was prepared for electrophoretic transfer.
Electrophoretic transfer and immunoblotting
Following 2D separation, the proteins on the second gel were transferred to an “Immun-Blot PVDF Membrane for Protein Blotting” using condition as previously described [17]. PBST, composed of Dulbecco’s Phosphate Buffered Saline + 1% Tween 20, was used as wash. BPBST (PBST+ 1% BSA + 1% normal goat serum) was used to block the membranes and for antibody dilutions except as noted.
A pool of serum from patients with confirmed ordinary scabies was prepared by combining equal volumes of 5 individual serum samples [18]. The serum pool was diluted 1/60 and used to probe the blot for 2 hrs. For IgM binding, the blot was probed for 1 hr in biotinylated-Goat anti-Human IgM at 1/5000 and 1hr in streptavidin-Alkaline Phosphatase at 1/5000 (both from Southern Biotechnology Associates, Birmingham, AL). Tris-buffered saline (TBS) replaced PBS in wash and diluent prior to the Alkaline Phosphatase step. The blot was developed using AP Blue Membrane Substrate (Sigma-Aldrich, St. Louis, MO) yielding blue spots where IgM bound. The blot was imaged and subsequently re-probed for IgG binding using biotinylated-Goat anti-Human IgG at 1/5000 and streptavidin-Horseradish Peroxidase at 1/5000 (Southern Biotechnology Associates). IgG binding proteins were stained reddish-brown using the substrate of Young [19]. Proteins that bound both IgM and IgG appeared purplish on the finished blot.
Stained spot selection and protein identification
Both the stained gel and probed immunoblot were imaged and the images were overlaid with a 1,000-cell grid (25 row x 40 cells/row) as described before [14]. This allowed each stained protein spot on the gel and on the corresponding blot to be assigned a unique “spot number” identifier.
Ninety-seven blue-stained spots were excised from the gel using a 1-mm spot picker, collected into labeled LoBind tubes (Eppendorf, Westbury, NY) and frozen. Samples were shipped to Applied Biomics (Hayward, CA) for trypsin digestion and sequencing by mass spectrometry. Proteins were identified by MASCOT (Matrix Science, London, UK) search of the National Center for Biotechnology Information non-redundant database (NCBInr) with taxonomy restricted to “Sarcoptes scabiei”. This database contains the complete genome and predicted proteome for S. scabiei var. canis [20].
Recombinant protein expression and purification
Gene sequences for selected proteins were synthesized by GenScript (Piscataway, NJ) with the open reading frame being codon-optimized for expression in E. coli. Additional modifications to the open reading frame were made to eliminate any internal BamHI, HindIII, and KpnI restriction sites. The termini of each gene contained in-frame 5' BamHI and 3' HindIII restriction sites for cloning into the pET-45b(+) expression vector. Expression vectors were transformed into E. coli Rosetta(DE3) competent cells (EMD Millipore, Billerica, MA). Transformants were selected on ampicillin-containing solid media plates, and 3-mL overnight liquid cultures were generated from five separate single colonies. The overnight cultures were incubated in liquid LB media that included ampicillin. All five cultures were then combined the following morning and subcultured into 500 mL of LB media without ampicillin for 3 hrs, followed by induction of protein expression by the addition of 1 mM (final concentration) IPTG for three hours. All liquid cultures were maintained in a MaxQ 4000 orbital shaking incubator (Thermo, Waltham, MA) shaking at 250 rpm and held at 32°C. Cells were harvested by centrifugation at 5000 x g for 20 min. Cell pellets were stored at -80°C until protein purification. Frozen cell pellets were resuspended in 10 mL of ice cold 1x Tris Buffered Saline (25 mM Tris, 150 mM NaCl, pH 7.2) containing Pierce Protease Inhibitor without EDTA (Thermo, Waltham, MA). Resuspended cells were disrupted by sonication on ice using 10 pulses of 30 sec on, 30 sec off with a 4710 series ultrasonic homogenizer (Cole Parmer, Vernon Hills, IL) set at 40% amplitude. Cellular debris was pelleted by centrifugation, and the supernatant was filtered through a 0.4 μm syringe filter. His-tagged proteins were then purified by column purification on Pierce His Pur Cobalt chromatography columns (Thermo) according to the manufacturer's recommendations and using a final elution volume of 3 mL. Purified proteins were quantified and analyzed as follows.
Immunoscreening of recombinant proteins
All recombinant proteins were subjected to an initial immunoblot screening. Aliquots of purified proteins (3–10 μg) were loaded onto the single prep-well of Mini-Protean TGX Any kD Gels and electrophoresis was carried out at 200 V as recommended by the manufacturer (BioRad) and as described previously [21, 22]. Separated proteins were then transferred to PVDF membranes that were blocked as described above.
Ten pools of serum from patients with confirmed scabies infestations were prepared based on prior assessment [13, 18]. A pool of serum from healthy control subjects was included as a negative control. All proteins were tested with these sera. Eight proteins of interest were also screened with serum from 30 individual patients with ordinary scabies and 10 uninfested controls [13, 18].
Blots were loaded into a mini-slot blot apparatus (Mini-Protean Multiscreen, BioRad) [21, 22] and probed for 2 hrs with the sera as described above. After removal from the slot blot apparatus, blots were sequentially developed for IgM and IgG binding as described above.
The purity of all individual proteins was also determined using electrophoresis on Mini-Protean TGX Any kD Gels run as above and stained with GelCode Blue.
Results
Our previous analysis revealed that most of the soluble proteins present in an aqueous extract of scabies mites had isoelectric points (pIs) in the range of pH 5–8 [14]. In the present analysis, we used preparative IEF to concentrate proteins with pIs in this vicinity and then used IPG strips of pH 5–8 for final separation.
Ninety-seven protein-containing spots were excised from the GelCode Coomassie blue stained gel and were submitted for sequence analysis (Fig 1). All 97 spots were identified as containing one or more proteins of S. scabiei var. canis (Table 1). There were a total of 50 different S. scabiei proteins identified and 34 of these had not been previously reported (Fig 1, Table 1). The proteins from an identical gel were transferred to a PVDF membrane that was probed using a pool of sera from 5 patients with confirmed ordinary scabies infections that had previously been determined to have high levels of circulating antibodies that recognized antigens in S. scabiei extracts [13, 18]. Of the 97 protein-containing spots, one bound only IgM, 32 bound only IgG and 29 bound both IgM and IgG (Fig 2, Table 1). No antibody bound to 33 of the spots.
Fig 1. GelCode Coomassie blue stained 2-dimensional electrophoresis gel used to separate proteins of S. scabiei.
Numbers in black denote those identified proteins observed only on the stained gel. Numbers in red indicate identified proteins that also bound antibody (immunoblot shown in Fig 2) from the serum of patients with ordinary scabies.
Table 1. Identification of the S. scabiei proteins in the 97 spots excised from the GelCode Blue stained 2-D gel (Fig 1) and their antibody binding profiles (Fig 2).
| MW | pI | |||||||
|---|---|---|---|---|---|---|---|---|
| Spot # | New | Accession # | Protein Identification | Pred | Gel | Pred | Gel | Ab Binding |
| 135 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 86,015 | 5.49 | 6.08 | None | |
| 136 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 85,976 | 5.49 | 6.15 | None | |
| 165 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 70,206 | 6.03 | 5.38 | IgM + IgG |
| 166 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 69,195 | 6.03 | 5.47 | IgM + IgG |
| 167 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 70,799 | 6.03 | 5.53 | IgM + IgG |
| 174 | KPM10172 | Sar s 28 (heat shock protein 70-like protein 6) | 77,075 | 71,005 | 6.50 | 6.01 | IgG only | |
| 175 | KPM10172 | Sar s 28 (heat shock protein 70-like protein 6) | 77,075 | 72,738 | 6.50 | 6.07 | IgG only | |
| 176 | KPM10172 | Sar s 28 (heat shock protein 70-like protein 6) | 77,075 | 74,713 | 6.50 | 6.15 | IgG only | |
| 177 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 75,188 | 5.49 | 6.22 | IgG only | |
| 179 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 74,328 | 5.49 | 6.35 | None | |
| 180 | ✔ | KPM08931 | Elongation factor G, mitochondrial-like protein | 84,242 | 73,932 | 7.53 | 6.42 | None |
| 201 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 60,438 | 6.03 | 5.10 | IgG only |
| 202 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 60,675 | 6.03 | 5.19 | IgG only |
| 209 | KPM06690 | 60 kDa Heat shock protein, mitochondrial-like protein | 62,505 | 61,556 | 5.77 | 5.67 | Neg stain | |
| 210 | KPM06690 | 60 kDa Heat shock protein, mitochondrial-like protein | 62,505 | 62,973 | 5.77 | 5.72 | Neg stain | |
| 225 | ✔ | KPM07637 | Actin-interacting protein 1-like protein | 64,294 | 62,437 | 6.07 | 6.78 | IgG only |
| 226 | ✔ | KPM07637 | Actin-interacting protein 1-like protein | 64,294 | 62,437 | 6.07 | 6.78 | IgG only |
| 227 | ✔ | KPM07637 | Actin-interacting protein 1-like protein | 64,294 | 63,960 | 6.07 | 6.90 | IgG only |
| 248 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 53,200 | 6.03 | 5.60 | None |
| 249 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 52,287 | 6.03 | 5.68 | None |
| 251 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 51,639 | 6.03 | 5.81 | None |
| 256 | KPM02829 | Enolase-like protein | 47,320 | 53,202 | 5.75 | 6.16 | IgG only | |
| 257 | KPM02829 | Enolase-like protein | 47,320 | 53,321 | 5.75 | 6.22 | IgG only | |
| 262 | ✔ | KPM04850 | Alpha-aminoadipic semialdehyde dehydrogenase-like protein | 59,780 | 53,297 | 6.77 | 6.56 | IgG only |
| 263 | ✔ | KPL93612 | Pyruvate kinase-like protein | 56,757 | 54,597 | 6.03 | 6.63 | IgG only |
| 298 | KPM02829 | Enolase-like protein | 47,320 | 47,163 | 5.75 | 6.30 | IgM + IgG | |
| 303 | ✔ | KPM04598 | Hypothetical protein QR98_0030480 | 53,449 | 48,048 | 6.13 | 6.65 | IgM + IgG |
| 306 | ✔ | KPM04598 | Hypothetical protein QR98_0030480 | 53,449 | 48,011 | 6.13 | 6.84 | IgM + IgG |
| 328 | ACC85688 | Actin | 41,570 | 42,022 | 5.22 | 5.61 | IgM + IgG | |
| 329 | KPM11937 | Actin-like protein 6 | 16,941 | 42,138 | 4.66 | 5.68 | IgM + IgG | |
| 335 | ✔ | KPM03560 | Sar s 27 allergen (serpin-like protein 9) | 46,965 | 40,933 | 5.68 | 6.08 | IgG only |
| 336 | KPM02829 | Enolase-like protein | 47,320 | 40,307 | 5.75 | 6.17 | IgG only | |
| 338 | KPM02829 | Enolase-like protein | 47,320 | 40,313 | 5.75 | 6.30 | IgG only | |
| 339 | ✔ | KPM09149 | Fumarylacetoacetase-like protein | 47,804 | 41,329 | 5.77 | 6.36 | IgM + IgG |
| 340 | KPM02829 | Enolase-like protein | 47,320 | 40,148 | 5.75 | 6.43 | IgG only | |
| 341 | ✔ | KPM09149 | Fumarylacetoacetase-like protein | 47,804 | 42,081 | 5.77 | 6.49 | IgM + IgG |
| 356 | ✔ | KPM04355 | Isocitrate dehydrogenase [NADP] cytoplasmic-like protein | 46,226 | 41,590 | 6.80 | 7.53 | IgM + IgG |
| 384* | KPM02376 | Sar s 20 allergen (arginine kinase like 1) | 33,971 | 36,036 | 6.29 | 6.70 | IgG only | |
| 384* | ✔ | KPM11752 | Hypothetical protein QR98_0103270 | 39,594 | 8.07 | IgG only | ||
| 386* | KPM02376 | Sar s 20 allergen (arginine kinase like 1) | 33,971 | 36,128 | 6.29 | 6.85 | IgG only | |
| 386* | ✔ | KPM11752 | Hypothetical protein QR98_0103270 | 39,594 | 8.07 | IgG only | ||
| 389* | KPM02376 | Sar s 20 allergen (arginine kinase like 1) | 33,971 | 36,087 | 6.29 | 7.05 | IgG only | |
| 389* | ✔ | KPM11752 | Hypothetical protein QR98_0103270 | 39,594 | 8.07 | IgG only | ||
| 390* | KPM02376 | Sar s 20 allergen (arginine kinase like 1) | 33,971 | 36,618 | 6.29 | 7.13 | IgG only | |
| 390* | ✔ | KPM11752 | Hypothetical protein QR98_0103270 | 39,594 | 8.07 | IgG only | ||
| 392 | KPM02376 | Sar s 20 allergen (arginine kinase like 1) | 33,971 | 36,162 | 6.29 | 7.25 | IgG only | |
| 397 | ✔ | KPM11752 | Hypothetical protein QR98_0103270 | 39,594 | 36,692 | 8.07 | 7.62 | IgG only |
| 401 | AFH08744 | Tropomyosin | 32,907 | 32,450 | 4.75 | 5.12 | None | |
| 407 | KPM02829 | Enolase-like protein | 47,320 | 33,449 | 5.75 | 5.54 | None | |
| 410 | ✔ | KPM05552 | Sar s 32 allergen (inorganic pyrophosphatase-like protein) | 34,225 | 33,805 | 5.40 | 5.75 | IgG only |
| 412 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 33,131 | 6.03 | 5.88 | None |
| 416 | ✔ | KPM08991 | Hypothetical protein QR98_0075200 | 9,170 | 32,823 | 6.73 | 6.17 | None |
| 418 | ✔ | KPM08991 | Hypothetical protein QR98_0075200 | 9,170 | 32,135 | 6.73 | 6.29 | None |
| 419 | ✔ | KPM06764 | Mediator of RNA polymerase II transcription subunit 8-like protein | 26,845 | 32,255 | 7.79 | 6.37 | None |
| 425 | ✔ | KPM03187 | Ester hydrolase C11orf54-like protein | 36,806 | 32,243 | 6.11 | 6.77 | IgM + IgG |
| 430 | ✔ | KPM05576 | Glyceraldehyde-3-phosphate dehydrogenase 2-like protein | 36,680 | 33,062 | 6.67 | 7.12 | IgM + IgG |
| 432 | KPM02376 | Sar s 20 allergen (arginine kinase like 1) | 33,971 | 33,121 | 6.29 | 7.25 | IgG only | |
| 434 | ✔ | KPM05576 | Glyceraldehyde-3-phosphate dehydrogenase 2-like protein | 36,680 | 33,121 | 6.67 | 7.38 | IgM + IgG |
| 435 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 32,425 | 6.03 | 7.46 | None |
| 442 | AFH08744 | Tropomyosin | 32,907 | 29,803 | 4.75 | 5.20 | None | |
| 458 | ✔ | KPM10460 | Glyoxalase domain-containing protein 4-like protein | 30,916 | 29,727 | 5.23 | 6.29 | IgG only |
| 460 | ✔ | KPM10460 | Glyoxalase domain-containing protein 4-like protein | 30,916 | 29,561 | 5.23 | 6.43 | IgG only |
| 468 | KPM04864 | Malate dehydrogenase, cytoplasmic-like protein | 34,948 | 28,983 | 6.07 | 6.97 | IgM + IgG | |
| 471 | KPM04864 | Malate dehydrogenase, cytoplasmic-like protein | 34,948 | 29,124 | 6.07 | 7.19 | IgM + IgG | |
| 528 | ✔ | KPM11752 | Hypothetical protein QR98_0103270 | 39,594 | 23,785 | 8.07 | 5.59 | None |
| 529 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 24,258 | 5.49 | 5.68 | IgG only | |
| 538 | ✔ | KPM02928 | Citrate synthase 1, mitochondrial-like protein | 51,707 | 24,123 | 7.75 | 6.30 | None |
| 541 | ✔ | KPM04580 | Sar s 16 allergen (gelsolin-like protein) | 54,930 | 23,992 | 6.08 | 6.50 | None |
| 569 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 22,281 | 5.49 | 5.68 | IgG only | |
| 572 | KPM11560 | Sar s 28 (heat shock protein 70-like protein 8) | 62,302 | 22,111 | 5.49 | 5.88 | IgG only | |
| 576* | ✔ | KPM11822 | Dehydrogenase/reductase SDR family member 2-like protein | 58,241 | 22,320 | 8.09 | 6.16 | IgM + IgG |
| 576* | ✔ | KPM03144 | Haloacid dehalogenase-like hydrolase domain-containing protein | 31,713 | 5.63 | IgM + IgG | ||
| 577 | ✔ | KPM02528 | Proteasome subunit beta type-4-like protein | 27,132 | 22,360 | 5.79 | 6.21 | IgM + IgG |
| 580 | ✔ | KPM11822 | Dehydrogenase/reductase SDR family member 2-like protein | 58,241 | 22,082 | 8.09 | 6.44 | IgM + IgG |
| 581 | ✔ | KPM11822 | Dehydrogenase/reductase SDR family member 2-like protein | 58,241 | 21,974 | 8.09 | 6.49 | IgM + IgG |
| 585 | ✔ | KPM11822 | Dehydrogenase/reductase SDR family member 2-like protein | 58,241 | 22,073 | 8.09 | 6.79 | IgM + IgG |
| 620 | ✔ | KPM02662 | Proteasome subunit alpha type-2-like protein | 47,963 | 20,507 | 10.13 | 6.43 | IgG only |
| 621 | ACX33880 | Glutathione S-transferase delta class 3, partial | 21,192 | 20,680 | 6.13 | 6.49 | None | |
| 626* | ✔ | KPM09477 | Proteasome subunit alpha type-6-like protein | 26,986 | 20,751 | 6.24 | 6.85 | IgM + IgG |
| 626* | ✔ | KPM10536 | Short-chain alcohol dehydrogenase-like protein | 26,299 | 5.57 | IgM + IgG | ||
| 628 | KPM10468 | Sar s 25 allergen (triosephosphate isomerase-like protein) | 26,678 | 20,128 | 6.13 | 6.99 | IgM + IgG | |
| 649 | ✔ | KPM04725 | Sar s 30 allergen (ferritin-like protein 3) | 21,807 | 19,090 | 5.19 | 5.66 | None |
| 651 | ✔ | KPM04725 | Sar s 30 allergen (ferritin-like protein 3) | 21,807 | 18,916 | 5.19 | 5.80 | IgG only |
| 656 | ✔ | KPM04725 | Sar s 30 allergen (ferritin-like protein 3) | 21,807 | 19,261 | 5.19 | 6.15 | None |
| 658 | ✔ | KPM03215 | Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein | 20,465 | 18,433 | 5.87 | 6.30 | IgM + IgG |
| 671 | ✔ | KPM03215 | Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein | 20,465 | 18,655 | 5.87 | 7.17 | IgM + IgG |
| 702 | ✔ | KPM03215 | Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein | 20,465 | 17,609 | 5.87 | 6.58 | None |
| 773 | ✔ | KPM03156 | 14-3-3 protein-like protein 1 | 28,027 | 15,193 | 4.79 | 5.95 | IgM only |
| 774 | ✔ | KPM06865 | Disulfide-isomerase A3-like protein | 59,046 | 15,064 | 5.78 | 6.02 | None |
| 776* | KPL97138 | Stress-induced-phosphoprotein 1-like protein | 37,044 | 7.53 | None | |||
| 776* | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 15,071 | 6.03 | 6.16 | None |
| 785 | ✔ | KPM11739 | Superoxide dismutase [Cu-Zn]-like protein | 16,109 | 14,874 | 6.02 | 6.76 | None |
| 812 | ✔ | KPM08623 | Sar s 31 allergen (cofilin-like protein) | 16,821 | 13,931 | 5.95 | 5.88 | IgM + IgG |
| 816 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 13,965 | 6.03 | 6.16 | None |
| 817 | ✔ | KPM08623 | Sar s 31 allergen (cofilin-like protein) | 16,821 | 13,923 | 5.95 | 6.22 | IgM + IgG |
| 820 | ✔ | KPM02263 | Vitellogenin-like protein | 220,647 | 14,107 | 6.03 | 6.45 | None |
| 831 | KPM06968 | Nucleoside diphosphate kinase B-like protein | 14,100 | 14,241 | 9.88 | 7.21 | IgM + IgG | |
| 897 | ✔ | KPM07763 | Sar s 13 allergen (lipocalin-like protein) | 14,867 | 12,328 | 6.37 | 6.24 | IgM + IgG |
| 901 | ✔ | KPM07609 | CUB domain containing protein 4 | 122,775 | 12,301 | 5.67 | 6.50 | None |
| 928 | KPM09467 | Thioredoxin-like protein 2 | 11,704 | 11,508 | 5.06 | 5.60 | None | |
| 930 | ✔ | KPM04598 | Hypothetical protein QR98_0030480 | 53,449 | 11,587 | 6.13 | 5.73 | None |
| 934 | ✔ | KPL94049 | Muscular protein 20-like protein | 15,837 | 11,581 | 6.73 | 6.02 | None |
| 936* | ✔ | KPM03769 | Hypothetical protein QR98_0022030 | 18,008 | 11,514 | 4.81 | 6.15 | None |
| 936* | ✔ | KPL94049 | Muscular protein 20-like protein | 15,837 | 6.73 | None | ||
| 941 | ✔ | KPL94049 | Muscular protein 20-like protein | 15,837 | 11,560 | 6.73 | 6.51 | None |
* indicates that the spot contained a mixture of proteins. ✔ denotes proteins that were not previously identified [14]. Molecular weights (MW) and isoelectric points (pI) predicted for each protein and determined from the gel are given. Immunoblot binding of IgM only, IgG only or both IgM and IgG is indicated. Some proteins did not bind antibody (None) and two proteins appeared negatively stained (white spots) on the immunoblot.
Fig 2. Immunoblot of 2-dimensional electrophoresis gel used to separate proteins of S. scabiei.
Numbers in red indicate identified proteins that bound antibody from the serum of patients with ordinary scabies.
We previously postulated that a diagnostic test for scabies would require identifying a set of antigens that selectively bind antibody (especially IgM) from the serum of patients suspected of being infected with scabies mites [13]. Based on the antibody-binding profiles of the proteins identified on the 2D gel and blot, we selected 14 proteins for further study as diagnostic antigen candidates (Table 2). We also selected 9 additional proteins from the > 150 previously-identified proteins that could be among the molecules that are responsible for this mite’s ability to modulate its host’s immune responses (Table 2) [12, 14]. The genes coding for these 23 proteins were deduced from the S. scabiei var. canis genome [20], chemically synthesized, and cloned into E. coli. The recombinant proteins were expressed and partially purified before being subjected to immunoblot screening. GelCode Coomassie blue stained gels showed that the purity of the recombinant proteins ranged from 10% to 95%.
Table 2. First round screening of recombinant S. scabiei proteins for their ability to bind IgM and/or IgG from the serum of patients with ordinary scabies.
| Accession # | Protein Identification | IgM | IgG | IgM -/+ IgG |
|---|---|---|---|---|
| Diagnostic antigen candidates | ||||
| KPM03156 | 14-3-3 protein-like protein 1 | 7/10 | 10/10 | 10/10 |
| KPM09740 | 2,3-bisphosphoglycerate-independent phosphoglycerate mutase-like protein | - | - | - |
| KPM11822 | Dehydrogenase/reductase SDR family member 2-like protein | - | 1/10 | 1/10 |
| KPM02829 | Enolase-like protein | 10/10 | 10/10 | 10/10 |
| KPM03144 | Haloacid dehalogenase-like hydrolase domain-containing protein | - | 2/10 | 2/10 |
| KPM04864 | Malate dehydrogenase, cytoplasmic-like protein | - | - | - |
| KPM03215 | Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein | 4/10 | 5/10 | 5/10 |
| KPM09477 | Proteasome subunit alpha type-6-like protein | - | - | - |
| KPM07763 | Sar s 13 allergen (lipocalin-like protein) | 3/10 | 10/10 | 10/10 |
| KPM10468 | Sar s 25 allergen (triosephosphate isomerase-like protein) | 10/10 | 10/10 | 10/10 |
| KPM08623 | Sar s 31 allergen (cofilin-like protein) | 5/10 | 10/10 | 10/10 |
| KPM10536 | Short-chain alcohol dehydrogenase-like protein | - | - | - |
| KPM11752 | Hypothetical protein QR98_0103270 | 10/10 | 10/10 | 10/10 |
| KPM04725 | Sar s 30 allergen (ferritin-like protein 3) | 3/10 | 10/10 | 10/10 |
| Immunomodulatory molecule candidates | ||||
| KPM11739 | Superoxide dismutase [Cu-Zn]-like protein | - | - | - |
| KPM07532 | Calmodulin-like | - | 2/10 | 2/10 |
| KPM04170 | Calreticulin-like | 1/10 | - | 1/10 |
| KPM09372 | Cystatin-C-like protein | - | - | - |
| KPM09373 | Cystatin-like protein | - | - | - |
| KPM09123 | Hypothetical protein QR98_0076540 | - | - | - |
| KPM07951 | Mannan-binding lectin serine protease 1-like | - | - | - |
| KPM05304 | Matrix metalloproteinase-like | - | - | - |
| KPM02741 | Membrane metallo-endopeptidase-like 1-like | 1/10 | 2/10 | 2/10 |
Each protein was tested with 10 pools of serum from patients with ordinary scabies. The number of pools out of 10 that had specific antibody isotypes directed at each protein is shown.
For the first round of immunoscreening, ten pools of serum from patients with confirmed scabies infections were prepared based on prior screening [13, 18]. Another pool of sera from uninfected subjects was also prepared to serve as a negative control. Each of the 23 proteins was then screened with these 11 serum pools by slot blot. Eight of the 14 proteins that were selected as diagnostic antigen candidates were recognized by antibodies in ≥ 50% of the test serum pools (Table 2). None of the candidate immunomodulatory proteins bound antibodies in more than 20% of the test sera.
The 8 most promising diagnostic antigen candidates were subjected to a second round of screening using the serum of 30 individual US patients with ordinary scabies and 10 uninfected controls [13, 18]. One protein (KPM11752), a hypothetical protein that appears unique to scabies mites, was recognized by antibodies present in the serum of all scabies patients and all control subjects (Table 3). Three other proteins (KPM03215, KPM07763 and KPM10468) bound antibodies present in the serum of 40–67% of the scabies patients but they were also recognized by 10–40% of the control sera. Two of these are homologs of the Group 13 and 25 dust mite allergens. The remaining candidate proteins were recognized by ≤ 30% of the serum from the scabies patients.
Table 3. Second round screening of recombinant S. scabiei proteins for their ability to bind IgM and/or IgG from the serum of patients with ordinary scabies and from uninfected control subjects.
| Patients | Controls | ||||
|---|---|---|---|---|---|
| Accession # | Protein Identification | IgM | IgG | IgM -/+ IgG | IgM -/+ IgG |
| KPM03156 | 14-3-3 protein-like protein 1 | 4/30 | 7/30 | 7/30 | 2/10 |
| KPM02829 | Enolase-like protein | 0/30 | 3/30 | 3/30 | 0/10 |
| KPM03215 | Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein | 12/30 | 12/30 | 12/30 | 1/10 |
| KPM07763 | Sar s 13 allergen (lipocalin-like protein) | 11/30 | 15/30 | 20/30 | 4/10 |
| KPM10468 | Sar s 25 allergen (triosephosphate isomerase-like protein) | 6/30 | 7/30 | 13/30 | 3/10 |
| KPM08623 | Sar s 31 allergen (cofilin-like protein) | 9/30 | 9/30 | 9/30 | 3/10 |
| KPM11752 | Hypothetical protein QR98_0103270 | 30/30 | 30/30 | 30/30 | 10/10 |
| KPM04725 | Sar s 30 allergen (ferritin-like protein 3) | 3/30 | 3/30 | 5/30 | 0/10 |
Each protein was tested with serum from 30 individual patients with ordinary scabies and from 10 uninfected control subjects. The number of individual sera out of 30 that had specific antibody isotypes directed at each protein is shown.
Discussion
This research builds on previous proteomic work by identifying 50 different proteins produced by S. scabiei, 34 of which were not identified previously [14]. We determined that 66% of the protein-containing spots were recognized by IgM and/or IgG that is circulating in the serum of patients with ordinary scabies at the time of initial diagnosis and selected 14 of these for screening as candidates for use in a diagnostic test for scabies. Additionally, we identified 33 protein-containing spots, representing 16 different proteins, that were isolated from a Coomassie blue stained gel that did not bind patient antibody. Included among this set of proteins may be molecules that participate in the parasite’s immune evasion mechanisms and are responsible for modulating the host’s immune responses [1–12].
Unfortunately none of the 14 proteins selected as potential diagnostic antigens shows enough promise to warrant further study. Only two proteins (KPM07763 and KPM11752) had sensitivities of ≥ 67% but neither offered a specificity of > 40% (Table 3). An additional 19 different antibody-binding proteins were identified on the 2D immunoblot and these are also potential candidates for use as diagnostic antigens (Table 1, Fig 2). It is possible that screening of these proteins could yield candidates promising better sensitivity and specificity than those reported here.
Perhaps more interesting are the data for the 9 proteins selected for the possibility that they may be immunomodulatory. All were identified in a previous study [14] or were predicted from the genome [20] and none were detected on the 2D immunoblot (Fig 2). Among these were calmodulin-, calreticulin- and cystatin-like proteins, all of which have been shown to be produced by other parasites and to possess immunomodulatory properties [23, 24]. For a protein to be effective in assisting the mite to evade the host’s immune response it would likely also be able to escape detection by the adaptive immune system and would not elicit an antibody response. As would be expected, 3 of the 9 proteins tested were recognized by antibodies in the serum of ≤ 20% of the scabietic patients while the other 6 did not bind any antibody. A logical next step would be to test these proteins for their immunomodulatory properties, although this was beyond the scope of the present study.
Conclusions
Thirty-three proteins that bound IgM and/or IgG from the serum of patients with ordinary scabies were identified. Although none of the 14 tested are useful for inclusion in a diagnostic test, the identity of 19 other candidates is provided. The identity of 16 proteins that are not recognized as antigens by infected patients was also determined. These could be among the molecules that are responsible for this mite’s ability to modulate its host’s innate and adaptive immune responses.
Acknowledgments
The authors thank DiAnn Vyszenski-Moher for technical assistance in culturing the mites used in this study. We also gratefully acknowledge the contribution of the late Stephen A. Estes, M.D. who provided the serum from the scabies patients. We are also grateful for the use of the equipment in the Wright State University Proteomics Analysis Laboratory.
Data Availability
All relevant data are provided within the paper.
Funding Statement
Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI017252 to LGA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Arlian LG, Vyszenski-Moher DL, Rapp CM, Hull BE. Production of IL-1 alpha and IL-1 beta by human skin equivalents parasitized by Sarcoptes scabiei. J Parasitol. 1996. October;82(5):719–23. [PubMed] [Google Scholar]
- 2.Arlian LG, Morgan MS, Neal JS. Modulation of cytokine expression in human keratinocytes and fibroblasts by extracts of scabies mites. Am J Trop Med Hyg. 2003. December;69(6):652–6. [PubMed] [Google Scholar]
- 3.Arlian LG, Morgan MS, Neal JS. Extracts of scabies mites (Sarcoptidae: Sarcoptes scabiei) modulate cytokine expression by human peripheral blood mononuclear cells and dendritic cells. J Med Entomol. 2004. January;41(1):69–73. [DOI] [PubMed] [Google Scholar]
- 4.Lalli PN, Morgan MS, Arlian LG. Skewed Th1/Th2 immune response to Sarcoptes scabiei. J Parasitol. 2004. August;90(4):711–4. doi: 10.1645/GE-214R [DOI] [PubMed] [Google Scholar]
- 5.Arlian LG, Morgan MS, Paul CC. Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J Med Entomol. 2006. March;43(2):283–7. [DOI] [PubMed] [Google Scholar]
- 6.Elder BL, Arlian LG, Morgan MS. Sarcoptes scabiei (Acari: Sarcoptidae) mite extract modulates expression of cytokines and adhesion molecules by human dermal microvascular endothelial cells. J Med Entomol. 2006. September;43(5):910–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Arlian LG, Fall N, Morgan MS. In vivo evidence that Sarcoptes scabiei (Acari: Sarcoptidae) is the source of molecules that modulate splenic gene expression. J Med Entomol. 2007. November;44(6):1054–63. [DOI] [PubMed] [Google Scholar]
- 8.Elder BL, Arlian LG, Morgan MS. Modulation of human dermal microvascular endothelial cells by Sarcoptes scabiei in combination with proinflammatory cytokines, histamine, and lipid-derived biologic mediators. Cytokine. 2009. August;47(2):103–11. doi: 10.1016/j.cyto.2009.05.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mullins JS, Arlian LG, Morgan MS. Extracts of Sarcoptes scabiei De Geer downmodulate secretion of IL-8 by skin keratinocytes and fibroblasts and of GM-CSF by fibroblasts in the presence of proinflammatory cytokines. J Med Entomol. 2009. July;46(4):845–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Morgan MS, Arlian LG. Response of human skin equivalents to Sarcoptes scabiei. J Med Entomol. 2010;47:877–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Morgan MS, Arlian LG, Markey MP. Sarcoptes scabiei mites modulate gene expression in human skin equivalents. PLoS One. 2013. August 5;8(8):e71143 doi: 10.1371/journal.pone.0071143 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Arlian LG, Morgan MS, Rider SD Jr. Sarcoptes scabiei: genomics to proteomics to biology. Parasit Vectors. 2016. July 1;9(1):380,016-1663-6. doi: 10.1186/s13071-016-1663-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Arlian LG, Feldmeier H, Morgan MS. The potential for a blood test for scabies. PLoS Negl Trop Dis. 2015;9:e0004188 doi: 10.1371/journal.pntd.0004188 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Morgan MS, Arlian LG, Rider SD Jr, Grunwald WC Jr, Cool DR. A Proteomic Analysis of Sarcoptes scabiei (Acari: Sarcoptidae). J Med Entomol. 2016. May;53(3):553–61. doi: 10.1093/jme/tjv247 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976. May 7;72:248–54. [DOI] [PubMed] [Google Scholar]
- 16.Morgan MS, Arlian LG, Barnes KC, Fernandez-Caldas E. Characterization of the allergens of the house dust mite Euroglyphus maynei. J Allergy Clin Immunol. 1997. August;100(2):222–8. [DOI] [PubMed] [Google Scholar]
- 17.Arlian LG, Morgan MS, Estes SA, Walton SF, Kemp DJ, Currie BJ. Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol. 2004. January;41(1):74–7. [DOI] [PubMed] [Google Scholar]
- 18.Morgan MS, Arlian LG, Estes SA. Skin test and radioallergosorbent test characteristics of scabietic patients. Am J Trop Med Hyg. 1997. August;57(2):190–6. [DOI] [PubMed] [Google Scholar]
- 19.Young PR. Enhancement of immunoblot staining using a mixed chromogenic substrate. J Immunol Methods. 1989. July 26;121(2):295–6. [DOI] [PubMed] [Google Scholar]
- 20.Rider SD, Morgan MS, Arlian LG. Draft genome of the scabies mite. Parasites & vectors. 2015;8:585–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Yadav A, Elder BL, Morgan MS, Vyszenski-Moher DL, Arlian LG. Prevalence of serum IgE to storage mites in a southwestern Ohio population. Ann Allergy Asthma Immunol. 2006. February;96(2):356–62. doi: 10.1016/S1081-1206(10)61248-3 [DOI] [PubMed] [Google Scholar]
- 22.Arlian LG, Morgan MS. Serum antibody to Sarcoptes scabiei and house dust mite prior to and during infestation with S. scabiei. Vet Parasitol. 2000. July 4;90(4):315–26. [DOI] [PubMed] [Google Scholar]
- 23.Radulovic ZM, Kim TK, Porter LM, Sze SH, Lewis L, Mulenga A. A 24–48 h fed Amblyomma americanum tick saliva immuno-proteome. BMC Genomics. 2014. June 24;15:518,2164-15-518. doi: 10.1186/1471-2164-15-518 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Coronado S, Barrios L, Zakzuk J, Regino R, Ahumada V, Franco L, et al. A recombinant cystatin from Ascaris lumbricoides attenuates inflammation of DSS-induced colitis. Parasite Immunol. 2017. April;39(4): doi: 10.1111/pim.12425. Epub 2017 Apr 6. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All relevant data are provided within the paper.